Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1614, 2007-01, pp. : 9-9
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Bhanji N.H. Chouinard G. Margolese H.C.
European Neuropsychopharmacology, Vol. 14, Iss. 2, 2004-03 ,pp. :
Access to resources
Recommend
Olanzapine: an atypical antipsychotic for schizophrenia
Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 2, 2000-01 ,pp. :
Antipsychotic polypharmacy in schizophrenia in Canada
Inpharma, Vol. 1, Iss. 1296, 2001-01 ,pp. :
Guidelines for depot antipsychotic treatment in schizophrenia
By Kane J.M. Aguglia E. Altamura A.C. Gutierrez J.L.A. Brunello N. Fleischhacker W.W. Gaebel W. Gerlach J. Guelfi J.-D. Kissling W. Lapierre Y.D. Lindstrom E. Mendlewicz J. Racagni G. Carulla L.S. Schooler N.R.
European Neuropsychopharmacology, Vol. 8, Iss. 1, 1998-02 ,pp. :
Antipsychotic Polypharmacy in Schizophrenia: Benefits and Risks
By Barnes Thomas R.E. Paton Carol
CNS Drugs, Vol. 25, Iss. 5, 2011-05 ,pp. :